Safety of protease inhibitors in HIV-infected pregnant women

References

• ConnorEMSperlingRSGelberRReduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupN Engl J Med199433118117311807935654
   PubMed Web of Science ®Google Scholar
• GhanotakisEMillerLSpensleyACountry adaptation of the 2010 World Health Organization recommendations for the prevention of mother-to-child transmission of HIVBull World Health Organ2012901292193123284198
   PubMed Web of Science ®Google Scholar
• MandelbrotLLandreau-MascaroARekacewiczCLamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1JAMA2001285162083209311311097
   PubMed Web of Science ®Google Scholar
• TownsendCLCortina-BorjaMPeckhamCSTookeyPATrends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990–2006BJOG200811591078108618503577
   PubMed Web of Science ®Google Scholar
• ThorneCNewellMLSafety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern??Drug Saf200730320321317343429
   PubMed Web of Science ®Google Scholar
• Kesho Bora StudyGde VincenziITriple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trialLancet Infect Dis201111317118021237718
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGlobal Monitoring Framework and Strategy for the Global Plan Towards the Elimination of new HIV infections Among Children by 2015 and Keeping Their Mothers Alive (EMTCT) GenevaSwitzerlandWorld Health Organization2012
   Google Scholar
• TaylorGPClaydenPDharJBritish HIV Association guidelines for the management of HIV infection in pregnant women 2012HIV Med201213Suppl 28715722830373
   PubMed Web of Science ®Google Scholar
• ShapiroRLHughesMDOgwuAAntiretroviral regimens in pregnancy and breast-feeding in BotswanaN Engl J Med2010362242282229420554983
   PubMed Web of Science ®Google Scholar
• WilliamsIChurchillDAndersonJBritish HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012HIV Med201213Suppl 2185
   Google Scholar
• GrinerRWilliamsPLReadJSIn utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United StatesAIDS Patient Care STDS201125738539421992592
   PubMed Web of Science ®Google Scholar
• BaroncelliSTamburriniERavizzaMAntiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomesAIDS Patient Care STDS200923751352019530956
   PubMed Web of Science ®Google Scholar
• GingelmaierAEberleJKostBPProtease inhibitor-based antiretroviral prophylaxis during pregnancy and the development of drug resistanceClin Infect Dis201050689089420166821
   PubMed Web of Science ®Google Scholar
• SoudaSGaseitsiweSGeorgetteNNo clinically significant drug resistance mutations in HIV-1 subtype C infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT In BotswanaJ Acquir Immune Defic Syndr3282013 [Epub ahead of print.]
   Web of Science ®Google Scholar
• BriandNMandelbrotLBlancheSPrevious antiretroviral therapy for prevention of mother-to-child transmission of HIV does not hamper the initial response to PI-based multitherapy during subsequent pregnancyJ Acquir Immune Defic Syndr201157212613521436712
   PubMed Web of Science ®Google Scholar
• EllisGMHuangSHittiJFrenkelLMTeamPSSelection of HIV resistance associated with antiretroviral therapy initiated due to pregnancy and suspended postpartumJ Acquir Immune Defic Syndr201158324124721765365
   PubMed Web of Science ®Google Scholar
• WeinbergAForster-HarwoodJDaviesJSafety and tolerability of antiretrovirals during pregnancyInfect Dis Obst Gynecol2011201186767421603231
   PubMedGoogle Scholar
• OuyangDWBroglySBLuMLack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretroviralsAIDS201024110911419926957
   PubMed Web of Science ®Google Scholar
• LyonsFHopkinsSKelleherBMaternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancyHIV Med20067425526016630038
   PubMed Web of Science ®Google Scholar
• HittiJFrenkelLMStekAMMaternal toxicity with continuous nevirapine in pregnancy: results from PACTG 1022J Acquir Immune Defic Syndr200436377277615213559
   PubMed Web of Science ®Google Scholar
• GisolfEHDreezenCDannerSAWeelJLWeverlingGJPrometheus Study GroupRisk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine. Prometheus Study GroupClin Infect Dis20003151234123911073757
   PubMed Web of Science ®Google Scholar
• SulkowskiMSMehtaSHChaissonREThomasDLMooreRDHepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavirAIDS200418172277228415577540
   PubMed Web of Science ®Google Scholar
• TortiCLapadulaGAntinoriAHyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER CohortsInfection200937324424919471856
   PubMed Web of Science ®Google Scholar
• ZhangDChandoTJEverettDWPattenCJDehalSSHumphreysWGIn vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidationDrug Metab Dispos200533111729173916118329
   PubMed Web of Science ®Google Scholar
• RaynerCREschLDWynnHEEalesRSymptomatic hyperbilirubinemia with indinavir/ritonavir-containing regimenAnn Pharmacother200135111391139511724090
   PubMed Web of Science ®Google Scholar
• HamadaYNishijimaTWatanabeKHigh incidence of renal stones among HIV-infected patients on ritonavir-boosted atazanavir than in those receiving other protease inhibitor-containing antiretroviral therapyClin Infect Dis20125591262126922820542
   PubMed Web of Science ®Google Scholar
• GavardLGilSPeytavinGPlacental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion modelAm J Obstet Gynecol2006195129630116678781
   PubMed Web of Science ®Google Scholar
• CeccaldiPFGavardLMandelbrotLFunctional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion modelObstet Gynecol Int2009200972659319960055
   PubMedGoogle Scholar
• ForestierFde RentyPPeytavinGDohinEFarinottiRMandelbrotLMaternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion modelAm J Obstet Gynecol2001185117818111483925
   PubMed Web of Science ®Google Scholar
• CaseyBMBawdonREPlacental transfer of ritonavir with zidovudine in the ex vivo placental perfusion modelAm J Obstet Gynecol19981793 Pt 17587619757985
   PubMed Web of Science ®Google Scholar
• BawdonREThe ex vivo human placental transfer of the anti-HIV nucleoside inhibitor abacavir and the protease inhibitor amprenavirInfect Dis Obstet Gynecol1998662442469972485
   PubMedGoogle Scholar
• MarzoliniCRudinCDecosterdLATransplacental passage of protease inhibitors at deliveryAIDS200216688989311919490
   PubMed Web of Science ®Google Scholar
• MirochnickMDorenbaumAHollandDConcentrations of protease inhibitors in cord blood after in utero exposurePediatr Infect Dis J200221983583812352805
   PubMed Web of Science ®Google Scholar
• ChappuyHTreluyerJMReyEMaternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virusAm J Obstet Gynecol2004191255856215343237
   PubMed Web of Science ®Google Scholar
• RipamontiDCattaneoDMaggioloFAtazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transferAIDS200721182409241518025877
   PubMed Web of Science ®Google Scholar
• RobertsSSMartinezMCovingtonDLRodeRAPasleyMVWoodwardWCLopinavir/ritonavir in pregnancyJ Acquir Immune Defic Syndr200951445646119381099
   PubMed Web of Science ®Google Scholar
• EskerSAlbanoJUyJMonitoring the risk of birth defects associated with atazanavir exposure in pregnancyAIDS Patient Care STDS201226630731122404239
   PubMed Web of Science ®Google Scholar
• CotterAMGarciaAGDuthelyMLLukeBO’SullivanMJIs antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis200619391195120116586354
   PubMed Web of Science ®Google Scholar
• KourtisAPSchmidCHJamiesonDJLauJUse of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysisAIDS200721560761517314523
   PubMed Web of Science ®Google Scholar
• WattsDHWilliamsPLKacanekDCombination antiretroviral use and preterm birthJ Infect Dis2013207461262123204173
   PubMed Web of Science ®Google Scholar
• FioreSFerrazziENewellMLTrabattoniDClericiMProtease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapyJ Infect Dis2007195691491617299724
   PubMed Web of Science ®Google Scholar
• Grosch-WoernerIPuchKMaierRFIncreased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected womenHIV Med20089161318199167
   PubMed Web of Science ®Google Scholar
• YanovskiJAMillerKDKinoTEndocrine and metabolic evaluation of human immunodeficiency virus-infected patients with evidence of protease inhibitor-associated lipodystrophyJ Clin Endocrinol Metab19998461925193110372688
   PubMed Web of Science ®Google Scholar
• CheshireMKingstonMMcQuillanOGittinsMAre HIV-related factors associated with pre-term delivery in a UK inner city setting? J Int AIDS Soc201215618223
   Google Scholar
• AzriaEMoutafoffCSchmitzTPregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimenAntivir Ther200914342343219474476
   PubMed Web of Science ®Google Scholar
• PatelKShapiroDEBroglySBPrenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancyJ Infect Dis201020171035104420196654
   PubMed Web of Science ®Google Scholar
• SibiudeJWarszawskiJTubianaRPremature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis20125491348136022460969
   PubMed Web of Science ®Google Scholar
• PowisKMKitchDOgwuAIncreased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancyJ Infect Dis2011204450651421791651
   PubMed Web of Science ®Google Scholar
• TownsendCLTookeyPANewellMLCortina-BorjaMAntiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmissionAntivir Ther201015577578320710059
   PubMed Web of Science ®Google Scholar
• TownsendCLCortina-BorjaMPeckhamCSTookeyPAAntiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and IrelandAIDS20072181019102617457096
   PubMed Web of Science ®Google Scholar
• ShapiroRLRibaudoHPowisKChenJParekhNExtended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomesAIDS201226112012122126816
   PubMed Web of Science ®Google Scholar
• ChenJYRibaudoHJSoudaSHighly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in BotswanaJ Infect Dis2012206111695170523066160
   PubMed Web of Science ®Google Scholar
• ParekhNRibaudoHSoudaSRisk factors for very preterm delivery and delivery of very-small-for-gestational-age infants among HIV-exposed and HIV-unexposed infants in BotswanaInt J Gynaecol Obstet20111151202521767835
   PubMed Web of Science ®Google Scholar
• HaeriSShauerMDaleMObstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapyAm J Obstet Gynecol20092013315e311e31519733286
   PubMed Web of Science ®Google Scholar
• DolaCPKhanRDeNicolaNCombination antiretroviral therapy with protease inhibitors in HIV-infected pregnancyJ Perinat Med2011401515522044007
   PubMed Web of Science ®Google Scholar
• BriandNMandelbrotLLe ChenadecJNo relation between in-utero exposure to HAART and intrauterine growth retardationAIDS200923101235124319424054
   PubMed Web of Science ®Google Scholar
• IvanovicJNicastriEAnceschiMMTransplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant womenCurrent HIV Res200976620625
   Web of Science ®Google Scholar
• WimalasunderaRCLarbalestierNSmithJHPre-eclampsia, antiretroviral therapy, and immune reconstitutionLancet200236093401152115412387967
   PubMed Web of Science ®Google Scholar
• MawsonAREffects of antiretroviral therapy on occurrence of pre-eclampsiaLancet2003361935434734812559889
   PubMed Web of Science ®Google Scholar
• FrankKABuchmannEJSchackisRCDoes human immunodeficiency virus infection protect against pre-eclampsia-eclampsia?Obstet Gynecol2004104223824215291993
   PubMed Web of Science ®Google Scholar
• MattarRAmedAMLindseyPCSassNDaherSPre-eclampsia and HIV infectionEur J Obstet Gynecol Reprod Biol2004117224024115541864
   PubMed Web of Science ®Google Scholar
• SuyAMartinezECollOIncreased risk of pre-eclampsia and fetal death in HIV-infected pregnant women receiving highly active antiretroviral therapyAIDS2006201596616327320
   PubMed Web of Science ®Google Scholar
• BoyajianTShahPSMurphyKERisk of pre-eclampsia in HIV-positive pregnant women receiving HAART: a matched cohort studyJ Obstet Gynaecol Can201234213614122340062
   PubMedGoogle Scholar
• NoorMAParkerRAO’MaraEThe effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adultsAIDS200418162137214415577646
   PubMed Web of Science ®Google Scholar
• NoorMAFlintOPMaaJFParkerRAEffects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinicallyAIDS200620141813182116954722
   PubMed Web of Science ®Google Scholar
• NoorMAThe role of protease inhibitors in the pathogenesis of HIV-associated insulin resistance: cellular mechanisms and clinical implicationsCurr HIV/AIDS Rep20074312613417883998
   PubMedGoogle Scholar
• WattsDHBalasubramanianRMaupinRTJrMaternal toxicity and pregnancy complications in human immunodeficiency virus-infected women receiving antiretroviral therapy: PACTG 316Am J Obstet Gynecol2004190250651614981398
   PubMed Web of Science ®Google Scholar
• El BeitunePDuarteGFossMCEffect of antiretroviral agents on carbohydrate metabolism in HIV-1 infected pregnant womenDiabetes Metab Res Rev2006221596316021650
   PubMed Web of Science ®Google Scholar
• Gonzalez-TomeMIRamos AmadorJTGuillenSGestational diabetes mellitus in a cohort of HIV-1 infected womenHIV Med200891086887418983478
   PubMed Web of Science ®Google Scholar
• TangJHSheffieldJSGrimesJEffect of protease inhibitor therapy on glucose intolerance in pregnancyObstet Gynecol200610751115111916648418
   PubMed Web of Science ®Google Scholar
• HittiJAndersenJMcComseyGProtease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084Am J Obstet Gynecol20071964331e331e33717403409
   PubMed Web of Science ®Google Scholar
• AngerGJPiquette-MillerMMechanisms of reduced maternal and fetal lopinavir exposure in a rat model of gestational diabetesDrug Metab Dispos201139101850185921742899
   PubMed Web of Science ®Google Scholar
• OliveroOAFernandezJJAntiochosBBWagnerJLSt ClaireMEPoirierMCTransplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeysJ Acquir Immune Defic Syndr200229432332911917235
   PubMed Web of Science ®Google Scholar
• OliveroOARelevance of experimental models for investigation of genotoxicity induced by antiretroviral therapy during human pregnancyMutat Res2008658318419018295533
   PubMed Web of Science ®Google Scholar
• European Collaborative StudyExposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected womenJ Acquir Immune Defic Syndr200332438038712640195
   PubMed Web of Science ®Google Scholar
• GillsJJLopiccoloJTsurutaniJNelfinavir, a lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivoClin Cancer Res200713175183519417785575
   PubMed Web of Science ®Google Scholar
• GillsJJLopiccoloJDennisPANelfinavir, a new anti-cancer drug with pleiotropic effects and many paths to autophagyAutophagy20084110710918000394
   PubMed Web of Science ®Google Scholar
• MandelbrotLMazyFFloch-TudalCAtazanavir in pregnancy: impact on neonatal hyperbilirubinemiaEur J Obstet Gynecol Reprod Biol20111571182121492993
   PubMed Web of Science ®Google Scholar
• ConradieFZorrillaCJosipovicDSafety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant womenHIV Med201112957057921569187
   PubMed Web of Science ®Google Scholar
• Le ChenadecJMayauxMJGuihenneuc-JouyauxCBlancheSEnquete Perinatale Francaise Study GroupPerinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infantsAIDS200317142053206114502008
   PubMed Web of Science ®Google Scholar
• European Collaborative StudyLevels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothersAIDS200418152009201715577622
   PubMed Web of Science ®Google Scholar
• Feiterna-SperlingCWeizsaeckerKBuhrerCHematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infantsJ Acquir Immune Defic Syndr2007451435117356471
   PubMed Web of Science ®Google Scholar
• HeidariSMofensonLCottonMFMarlinkRCahnPKatabiraEAntiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected childrenJ Acquir Immune Defic Syndr201157429029621602695
   PubMed Web of Science ®Google Scholar
• SimonAWarszawskiJKariyawasamDAssociation of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothersJAMA20113061707821730243
   PubMed Web of Science ®Google Scholar
• TubianaRMandelbrotLDelmasSthe Primeva Study GroupLPV/r monotherapy during pregnancy for PMTCT of HIV-1: the PRIMEVA/ANRS 135 randomized trial, pregnancy outcomesPaper presented at the 18th Conference on Retroviruses and Opportunistic InfectionsBoston, MAFebruary 27 to March 2, 2011
   Google Scholar